SI-BONE Q2 EPS $(0.30) Beats $(0.41) Estimate, Sales $33.30M Beat $32.24M Estimate
Portfolio Pulse from Benzinga Newsdesk
SI-BONE (NASDAQ:SIBN) reported Q2 losses of $(0.30) per share, beating the analyst consensus estimate of $(0.41) by 26.83%. This is a 44.44% increase over losses from the same period last year. The company also reported quarterly sales of $33.30 million, beating the analyst consensus estimate of $32.24 million by 3.29%. This is a 30.15% increase over sales from the same period last year.
August 07, 2023 | 8:37 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
SI-BONE's Q2 results beat analyst estimates, showing an increase in sales and a decrease in losses compared to the same period last year.
SI-BONE's better than expected Q2 results, with increased sales and decreased losses, are likely to have a positive impact on the company's stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100